Usefulness of Running Wheel for Detection of Congestive Heart Failure in Dilated Cardiomyopathy Mouse Model

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Sugihara, Masami ^a   Odagiri, Fuminori ^a   Suzuki, Takeshi ^a   Murayama, Takashi ^a   Nakazato, Yuji ^a   Unuma, Kana ^b,c   Yoshida, Ken Ichi ^c   Daida, Hiroyuki ^a   Sakurai, Takashi ^a   Morimoto, Sachio ^d   Kurebayashi, Nagomi ^a  

^a JUNTENDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; MYOSIN HEAVY CHAIN BETA; TROPONIN T;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CAUSE OF DEATH; CONGESTIVE CARDIOMYOPATHY; CONGESTIVE HEART FAILURE; DEATH; ELECTROCARDIOGRAM; EXERCISE; GENOTYPE; HEART EJECTION FRACTION; HEART VENTRICLE ARRHYTHMIA; HEART WEIGHT; HISTOPATHOLOGY; LUNG ALVEOLUS MACROPHAGE; LUNG WEIGHT; MOUSE; MULTICENTER STUDY; NONHUMAN; QRS COMPLEX; QT PROLONGATION; RUNNING; SUDDEN DEATH; TREADMILL; VOLUNTARY MOVEMENT;

ANIMALS; ATRIAL NATRIURETIC FACTOR; BIOLOGICAL MARKERS; CAUSE OF DEATH; DISEASE MODELS, ANIMAL; ELECTROCARDIOGRAPHY; FIBROSIS; HEART FAILURE, DIASTOLIC; HUMANS; LUNG; MICE; MICE, TRANSGENIC; MYOCARDIUM; NATRIURETIC PEPTIDE, BRAIN; ORGAN SIZE; PHYSICAL CONDITIONING, ANIMAL; RUNNING;

EID: 84873181098     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0055514     Document Type: Article

References (32)

1. Okutucu S, Oto A, (2010) Risk stratification in nonischemic dilated cardiomyopathy: Current perspectives. Cardiology journal 17: 219-229.
2. Dec GW, Fuster V, (1994) Idiopathic dilated cardiomyopathy. N Engl J Med 331: 1564-1575.
3. Jefferies JL, Towbin JA, (2010) Dilated cardiomyopathy. Lancet 375: 752-762.
4. Morimoto S, (2008) Sarcomeric proteins and inherited cardiomyopathies. Cardiovasc Res 77: 659-666.
5. Lakdawala NK, Dellefave L, Redwood CS, Sparks E, Cirino AL, et al. (2010) Familial dilated cardiomyopathy caused by an alpha-tropomyosin mutation: the distinctive natural history of sarcomeric dilated cardiomyopathy. J Am Coll Cardiol 55: 320-329.
6. Du CK, Morimoto S, Nishii K, Minakami R, Ohta M, et al. (2007) Knock-in mouse model of dilated cardiomyopathy caused by troponin mutation. Circulation research 101: 185-194.
7. Luedde M, Ehlermann P, Weichenhan D, Will R, Zeller R, et al. (2010) Severe familial left ventricular non-compaction cardiomyopathy due to a novel troponin T (TNNT2) mutation. Cardiovascular research 86: 452-460.
8. Suzuki T, Shioya T, Murayama T, Sugihara M, Odagiri F, et al. (2012) Multistep ion channel remodeling and lethal arrhythmia precede heart failure in a mouse model of inherited dilated cardiomyopathy. PLoS One 7: e35353.
9. Kamisago M, Sharma SD, DePalma SR, Solomon S, Sharma P, et al. (2000) Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy. The New England journal of medicine 343: 1688-1696.
10. Morimoto S, Lu QW, Harada K, Takahashi-Yanaga F, Minakami R, et al. (2002) Ca(2+)-desensitizing effect of a deletion mutation Delta K210 in cardiac troponin T that causes familial dilated cardiomyopathy. Proceedings of the National Academy of Sciences of the United States of America 99: 913-918.
11. Zhan DY, Morimoto S, Du CK, Wang YY, Lu QW, et al. (2009) Therapeutic effect of {beta}-adrenoceptor blockers using a mouse model of dilated cardiomyopathy with a troponin mutation. Cardiovascular research 84: 64-71.
12. Wang YY, Morimoto S, Du CK, Lu QW, Zhan DY, et al. (2010) Up-regulation of type 2 iodothyronine deiodinase in dilated cardiomyopathy. Cardiovascular research 87: 636-646.
13. Millane T, Jackson G, Gibbs CR, Lip GY, (2000) ABC of heart failure. Acute and chronic management strategies. BMJ 320: 559-562.
14. Mann DL (2011) Braunwald's Heart Disease- A Textbook of Cardiovascular Medicine, 9th ed. In: Bonow RO, Mann DL, P ZD, Peter L, editors. 9th ed: W.B. Saunders.
15. Wang TJ, Evans JC, Benjamin EJ, Levy D, LeRoy EC, et al. (2003) Natural history of asymptomatic left ventricular systolic dysfunction in the community. Circulation 108: 977-982.
16. Medeiros A, Rolim NP, Oliveira RS, Rosa KT, Mattos KC, et al. (2008) Exercise training delays cardiac dysfunction and prevents calcium handling abnormalities in sympathetic hyperactivity-induced heart failure mice. J Appl Physiol 104: 103-109.
17. Watson PA, Reusch JE, McCune SA, Leinwand LA, Luckey SW, et al. (2007) Restoration of CREB function is linked to completion and stabilization of adaptive cardiac hypertrophy in response to exercise. American journal of physiology Heart and circulatory physiology 293: H246-259.
18. Lygate CA, Hunyor I, Medway D, de Bono JP, Dawson D, et al. (2009) Cardiac phenotype of mitochondrial creatine kinase knockout mice is modified on a pure C57BL/6 genetic background. J Mol Cell Cardiol 46: 93-99.
19. Goehringer C, Rutschow D, Bauer R, Schinkel S, Weichenhan D, et al. (2009) Prevention of cardiomyopathy in delta-sarcoglycan knockout mice after systemic transfer of targeted adeno-associated viral vectors. Cardiovascular research 82: 404-410.
20. Jing X, Yokoi T, Nakamura Y, Nakamura M, Shan L, et al. (1998) Pulmonary capillary hemangiomatosis: a unique feature of congestive vasculopathy associated with hypertrophic cardiomyopathy. Arch Pathol Lab Med 122: 94-96.
21. Unuma K, Shintani-Ishida K, Yahagi N, Tsushima K, Shimosawa T, et al. (2010) Restraint stress induces connexin-43 translocation via alpha-adrenoceptors in rat heart. Circ J 74: 2693-2701.
22. Lompre AM, Schwartz K, d'Albis A, Lacombe G, Van Thiem N, et al. (1979) Myosin isoenzyme redistribution in chronic heart overload. Nature 282: 105-107.
23. Miyata S, Minobe W, Bristow MR, Leinwand LA, (2000) Myosin heavy chain isoform expression in the failing and nonfailing human heart. Circ Res 86: 386-390.
24. Kuwahara K, Saito Y, Takano M, Arai Y, Yasuno S, et al. (2003) NRSF regulates the fetal cardiac gene program and maintains normal cardiac structure and function. EMBO J 22: 6310-6321.
25. Brum PC, Kosek J, Patterson A, Bernstein D, Kobilka B, (2002) Abnormal cardiac function associated with sympathetic nervous system hyperactivity in mice. Am J Physiol Heart Circ Physiol 283: H1838-1845.
26. Knollmann BC, Knollmann-Ritschel BE, Weissman NJ, Jones LR, Morad M, (2000) Remodelling of ionic currents in hypertrophied and failing hearts of transgenic mice overexpressing calsequestrin. J Physiol 525 Pt 2: 483-498.
27. Watanabe T, Takeda T, Omiya S, Hikoso S, Yamaguchi O, et al. (2008) Reduction in hemoglobin-oxygen affinity results in the improvement of exercise capacity in mice with chronic heart failure. J Am Coll Cardiol 52: 779-786.
28. Ojaimi C, Li W, Kinugawa S, Post H, Csiszar A, et al. (2005) Transcriptional basis for exercise limitation in male eNOS-knockout mice with age: heart failure and the fetal phenotype. Am J Physiol Heart Circ Physiol 289: H1399-1407.
29. Lerman I, Harrison BC, Freeman K, Hewett TE, Allen DL, et al. (2002) Genetic variability in forced and voluntary endurance exercise performance in seven inbred mouse strains. J Appl Physiol 92: 2245-2255.
30. Hayek S, Nemer M, (2011) Cardiac natriuretic peptides: from basic discovery to clinical practice. Cardiovasc Ther 29: 362-376.
31. Rundell VL, Geenen DL, Buttrick PM, de Tombe PP, (2004) Depressed cardiac tension cost in experimental diabetes is due to altered myosin heavy chain isoform expression. Am J Physiol Heart Circ Physiol 287: H408-413.
32. Shende P, Plaisance I, Morandi C, Pellieux C, Berthonneche C, et al. (2011) Cardiac raptor ablation impairs adaptive hypertrophy, alters metabolic gene expression, and causes heart failure in mice. Circulation 123: 1073-1082.